Table 1. Vascular Reactivity.
Effect of DHT on WT and Agt+/− mice vascular reactivity in response to phenylephrine-induced constriction (EC50 (µM)) (A) and % relaxation to acetylcholine at 5 × 10−6 M Acetylcholine (B).
| A | ||||
|---|---|---|---|---|
| EC50 (µM) to Phenylephrine |
Placebo | DHT | DHT + 20-HEDE |
DHT+ Lisinopril |
| WT Mice | 0.50 ± 0.06 | 0.12 ± 0.03 * | 0.60 ± 0.25 # | 0.37 ± 0.09*# |
| Agt+/− Mice | 0.56 ± 0.16 | 0.22 ± 0.06* † | 0.53 ± 0.14 # | 0.28 ± 0.04* |
| B | |||||
|---|---|---|---|---|---|
| % Relaxation (5 × 10−6 M Acetylcholine) |
Placebo | DHT | DHT + 20-HEDE |
DHT+ Lisinopril |
DHT+ 20-HEDE + 20-HETE (ex vivo) |
| WT Mice | 90 ± 2 | 26 ± 6* | 74 ± 9 # | 70 ± 9 # | 34 ± 13** |
| Agt+/− Mice | 87 ± 2 | 77 ± 4 | 71 ± 8 | 79 ± 9 | 48 ± 7** |
Results are mean ±SE (n=3–4).
p<0.05 vs Placebo-treated mice,
p<0.05 vs DHT-treated mice,
p<0.05 vs DHT-treated WT mice,
p<0.05 vs DHT+20-HEDE-treated mice.